Assessment of Therapeutic Effects of Acarbose and Metformin under Different β-Cell Function Status in Chinese Patients with Newly Diagnosed Type 2 Diabetes: Based on MARCH Trial

被引：0
|
作者：
Fu, Jing
Liu, Jia
Yang, Wenying
Wang, Guang
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
159-LB
引用
收藏
页码：LB42 / LB42
页数：1
相关论文
共 50 条
  • [1] Comparison of therapeutic effects of acarbose and metformin under different β-cell function status in Chinese patients with type 2 diabetes
    Fu, Jing
    Liu, Jia
    Xu, Yuan
    Yang, Ning
    Yang, Wenying
    Wang, Guang
    [J]. ENDOCRINE JOURNAL, 2019, 66 (05) : 443 - 450
  • [2] MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients
    Wang, Guang
    Liu, Jia
    Yang, Ning
    Gao, Xia
    Fan, Hui
    Xu, Yuan
    Yang, Wenying
    [J]. PLOS ONE, 2014, 9 (08):
  • [3] Factors that influence the efficacy of acarbose and metformin as initial therapy in Chinese patients with newly diagnosed type 2 diabetes: a subanalysis of the MARCH trial
    Zhang, Jinping
    Wang, Na
    Xing, Xiaoyan
    Yang, Zhaojun
    Wang, Xin
    Yang, Wenying
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (04) : 713 - 719
  • [4] MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
    Wang, Na
    Zhang, Jin-Ping
    Xing, Xiao-Yan
    Yang, Zhao-Jun
    Zhang, Bo
    Wang, Xin
    Yang, Wen-Ying
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (02) : 309 - 320
  • [5] Gender-differential effects on blood glucose levels between acarbose and metformin in Chinese patients with newly diagnosed type 2 diabetes: a sub-analysis of the MARCH trial
    Li, Jianxin
    Li, Jing
    Shan, Zhongyan
    Yang, Wenying
    Liu, Jie
    Tian, Haoming
    Zhou, Zhiguang
    Ji, Qiuhe
    Weng, Jianping
    Jia, Weiping
    Lu, Juming
    Liu, Jing
    Xu, Yuan
    Yang, Zhaojun
    [J]. ENDOCRINE JOURNAL, 2021, 68 (01) : 69 - 79
  • [6] Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial
    Pan, Qingrong
    Xu, Yuan
    Yang, Ning
    Gao, Xia
    Liu, Jia
    Yang, Wenying
    Wang, Guang
    [J]. MEDICINE, 2016, 95 (14)
  • [7] Comparative Assessment of Therapeutic Effects of Exenatide and Metformin in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
    Liu, Jia
    Hu, Yanjin
    Yang, Ning
    Jia, Yumei
    Xu, Yuan
    Wang, Guang
    [J]. DIABETES, 2016, 65 : A263 - A263
  • [8] Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
    Song, Lulu
    Kong, Xiaomu
    Yang, Zhaojun
    Zhang, Jinping
    Yang, Wenying
    Zhang, Bo
    Chen, Xiaoping
    Wang, Xin
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 4451 - 4458
  • [9] Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China
    Rong Zhang
    Quanxi Zhao
    Rong Li
    [J]. BMC Pharmacology and Toxicology, 23
  • [10] Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China
    Zhang, Rong
    Zhao, Quanxi
    Li, Rong
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
12345